This is an excerpt from From Wall Street Beats to Biotech Breakthroughs — Dean’s journey from DJ booths and banking to leading AI-driven clinical trial innovations (Part 4/6).

In this episode, host René Bastón, Venture Partner at Covenant Venture Capital, and Dean Zheng, Clinical Outsourcing Professional at Pfizer, dive into how AI is transforming the clinical trial process—especially in biostatistics and data management.

Dean explains how automation can cut the time for generating analysis datasets and statistical tables from three months to just one, while improving accuracy and reducing human error. He shares real examples of how AI tools help teams adapt instantly to new data, run analyses in minutes instead of hours, and ultimately accelerate time-to-market for critical treatments.

Tune in for valuable insights on:

Cutting trial timelines with AI-powered workflows

Improving data quality and reducing redundancy

Why speed matters for patients, sponsors, and investors

You can connect with our host, René Bastón, on LinkedIn:

And our guest, Dean Zheng, on LinkedIn: https://www.linkedin.com/in/dean-mingyang-zheng-0ab336108/

For more information on any of the topics discussed, visit the Hill Research Podcast at: